These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1388038)

  • 1. Intravenous clodronate for the treatment of hypercalcaemia in breast cancer patients with bone metastases--a prospective randomised placebo-controlled multicentre study.
    Rotstein S; Glas U; Eriksson M; Pfeiffer P; Hansen J; Söderqvist J; Bandmann U; Strid S
    Eur J Cancer; 1992; 28A(4-5):890-3. PubMed ID: 1388038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.
    Purohit OP; Radstone CR; Anthony C; Kanis JA; Coleman RE
    Br J Cancer; 1995 Nov; 72(5):1289-93. PubMed ID: 7577484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
    Plosker GL; Goa KL
    Drugs; 1994 Jun; 47(6):945-82. PubMed ID: 7521833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases].
    Tubiana-Hulin M; Beuzeboc P; Mauriac L; Barbet N; Frenay M; Monnier A; Pion JM; Switsers O; Misset JL; Assadourian S; Bessa E
    Bull Cancer; 2001 Jul; 88(7):701-7. PubMed ID: 11495824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of skeletal disease in breast cancer: a controlled clodronate trial.
    Elomaa I; Blomqvist C; Porkka L; Lamberg-Allardt C; Borgström GH
    Bone; 1987; 8 Suppl 1():S53-6. PubMed ID: 2961355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of malignant hypercalcaemia with clodronate.
    Percival RC; Paterson AD; Yates AJ; Beard DJ; Douglas DL; Neal FE; Russell RG; Kanis JA
    Br J Cancer; 1985 May; 51(5):665-9. PubMed ID: 3158326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of the hypercalcaemia of malignancy with intravenous clodronate.
    Urwin GH; Yates AJ; Gray RE; Hamdy NA; McCloskey EV; Preston FE; Greaves M; Neil FE; Kanis JA
    Bone; 1987; 8 Suppl 1():S43-51. PubMed ID: 2961354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.
    Paterson AH; Powles TJ; Kanis JA; McCloskey E; Hanson J; Ashley S
    J Clin Oncol; 1993 Jan; 11(1):59-65. PubMed ID: 8418243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a dose response relationship for clodronate in the treatment of tumour induced hypercalcaemia?
    Shah S; Hardy J; Rees E; Ling J; Gwilliam B; Davis C; Broadley K; A'Hern R
    Br J Cancer; 2002 Apr; 86(8):1235-7. PubMed ID: 11953878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group.
    Lahtinen R; Laakso M; Palva I; Virkkunen P; Elomaa I
    Lancet; 1992 Oct; 340(8827):1049-52. PubMed ID: 1357451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral clodronate in breast cancer patients with bone metastases: a randomized study.
    Kristensen B; Ejlertsen B; Groenvold M; Hein S; Loft H; Mouridsen HT
    J Intern Med; 1999 Jul; 246(1):67-74. PubMed ID: 10447227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026].
    Powles T; Paterson A; McCloskey E; Schein P; Scheffler B; Tidy A; Ashley S; Smith I; Ottestad L; Kanis J
    Breast Cancer Res; 2006; 8(2):R13. PubMed ID: 16542503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clodronate: a review of its use in breast cancer.
    Hurst M; Noble S
    Drugs Aging; 1999 Aug; 15(2):143-67. PubMed ID: 10495073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zoledronic acid and clodronate in the treatment of malignant bone metastases with hypercalcaemia; efficacy and safety comparative study.
    Sabry NA; Habib EE
    Med Oncol; 2011 Jun; 28(2):584-90. PubMed ID: 20204542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of skeletal disease in breast cancer with clodronate.
    Paterson AH; Ernst DS; Powles TJ; Ashley S; McCloskey EV; Kanis JA
    Bone; 1991; 12 Suppl 1():S25-30. PubMed ID: 1720012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, placebo-controlled, dose-response trial of oral clodronate in patients with bone metastases.
    O'Rourke N; McCloskey E; Houghton F; Huss H; Kanis JA
    J Clin Oncol; 1995 Apr; 13(4):929-34. PubMed ID: 7707121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clodronate decreases the frequency of skeletal metastases in women with breast cancer.
    Kanis JA; Powles T; Paterson AH; McCloskey EV; Ashley S
    Bone; 1996 Dec; 19(6):663-7. PubMed ID: 8968035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clodronate. A randomized study in the treatment of cancer-related hypercalcemia.
    Witte RS; Koeller J; Davis TE; Benson AB; Durie BG; Lipton A; Stock JL; Citrin DL; Jacobs TP
    Arch Intern Med; 1987 May; 147(5):937-9. PubMed ID: 2953318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate.
    Jacobs TP; Siris ES; Bilezikian JP; Baquiran DC; Shane E; Canfield RE
    Ann Intern Med; 1981 Mar; 94(3):312-6. PubMed ID: 6452846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double blind randomized study of oral clodronate in the treatment of bone metastases from tumors poorly responsive to chemotherapy.
    Piga A; Bracci R; Ferretti B; Sandri P; Nortilli R; Acito L; Pancotti A; Di Furia L; Carle F; Cellerino R
    J Exp Clin Cancer Res; 1998 Jun; 17(2):213-7. PubMed ID: 9700583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.